
About Panacea Biotec Pharma Limited
Data last updated:
Panacea Biotec Pharma Limited is a public limited company based in New Delhi, Delhi, India, a subsidiary of Panacea Biotec Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 March 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24299DL2019PLC347566. Its GSTIN is 07AAKCP4431B1ZQ (Delhi). The company holds 22 GST registrations, of which 21 are active.
The company has an authorised share capital of ₹60 Cr and a paid-up capital of ₹10 Lakh. It is led by directors including Rajesh Jain (Managing Director) and Ankesh Jain (Whole-Time Director).
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 1 Extension/A – 27 Mohan Co – Operative Industrial Estate Mathura Road, New Delhi, Delhi, India – 110044.
As per the financials filed for FY 2025, the company reported a revenue of ₹265.23 Cr, a growth of 26% compared to the previous year. For the same year it recorded a net profit of ₹16.94 Cr (net margin 6.4%) and EBITDA of ₹37.16 Cr (EBITDA margin 14%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 37% over five years.
The company has about 940 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Panacea Biotec. As per MCA filings, the company has satisfied charges of ₹1,618.44 Cr on record. Court records list 5 cases involving the company, including 1 filed by the company and 4 filed against it; 2 cases are pending. The company has 3 deals on record (2 debt financings, 1 acquisition), with disclosed funding of ₹808.43 Cr; the latest was in February 2022. Its 3 peer companies in the Healthcare industry (Formulations, Preventive Healthcare Supplements), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 1 smaller; the largest is Amn Life Science Private Limited with revenue of ₹273.11 Cr. The company has 34 MSME Form 1 returns on record between 2020 and 2024, listing 1,642 overdue payments to 181 micro and small suppliers.
For more details, the company can be reached via its website panaceabiotec.com.
Company details
CIN history
Panacea Biotec Pharma has one previous CIN (Corporate Identification Number): U24299PB2019PLC068319. The current CIN is U24299DL2019PLC347566, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24299DL2019PLC347566 | Current |
| U24299PB2019PLC068319 | Previous |
Contact details
Panacea Biotec Pharma Limited's registered office is in New Delhi, Delhi. Its website is panaceabiotec.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressB – 1 Extension/A – 27 Mohan Co – Operative Industrial Estate Mathura Road, New Delhi, Delhi, India – 110044
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Panacea Biotec Pharma Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Panacea Biotec Pharma operates one associated brand: Panacea Biotec. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Developer of biosimilars, vaccines and natural products | panaceabiotec.com |
Business activity
The main business activity of Panacea Biotec Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Panacea Biotec Pharma Limited, buy the company report.
Financials of Panacea Biotec Pharma Limited
FY 2025 filings availablePanacea Biotec Pharma Limited reported revenue of ₹265.23 Cr (up 26% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 37% over five years, including 26% growth in the latest year. EBITDA rose 201% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹265.23 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹37.16 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹16.94 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 14% | ||||
| Net Profit Margin | 6.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Panacea Biotec Pharma Limited, buy the company report.
Board of directors of Panacea Biotec Pharma Limited
Panacea Biotec Pharma has 6 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ankesh Jain Also directs: Panacea Biotec Limited, Adveta Power Private Limited | Whole-Time Director | 22 Mar 2019 | 7 Years 7 Months | Current |
| Rajesh Jain Also directs: Panacea Biotec Limited, Sundrop Brands Limited, Federal-Mogul Goetze (India) Limited and 4 more | Director | 12 Nov 2024 | 2 Years 0 Months | Current |
| Manjula Upadhyay | Director | 23 Jul 2021 | 5 Years 3 Months | Current |
| Narotam Kumar Juneja | Whole-Time Director | 01 Apr 2022 | 4 Years 7 Months | Current |
| Rajesh Jain | Managing Director | 22 Mar 2019 | 7 Years 7 Months | Current |
| Sanjay Trehan Also directs: Panacea Biotec Limited | Whole-Time Director | 13 Feb 2025 | 1 Years 9 Months | Current |
Peer comparison
Panacea Biotec Pharma Limited is compared with the 3 companies closest to it by revenue in the Healthcare industry (Formulations, Preventive Healthcare Supplements), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Amn Life Science Private Limited | ₹273.11 Cr (FY 2025) | 42.0% | Mumbai, Maharashtra, India | |||
| Selmar Lab Private Limited | ₹269.27 Cr (FY 2024) | -14.0% | Hyderabad, Telangana, India | |||
| Panacea Biotec Pharma Limitedthis company | ₹265.23 Cr (FY 2025) | ₹16.94 Cr | 6.4% | 26.0% | 940 | New Delhi, Delhi, India |
| Psychotropics India Limited | ₹261.89 Cr (FY 2025) | -8.0% | Faridabad, Haryana, India |
To see the full peer comparison of Panacea Biotec Pharma Limited, buy the company report.
Auditor
Panacea Biotec Pharma Limited is audited by Suresh Surana & Associates LLP for the financial year 2025.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Suresh Surana & Associates LLP | FY 2025 | 121750W/W100010 |
Shareholding
The shareholding of Panacea Biotec Pharma Limited is on record for 5 financial years, the latest being FY 2025, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Panacea Biotec Pharma Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 01 Feb 2020 | 100332250 | Others | ₹754.44 Cr | Satisfied | |
| 06 Apr 2019 | 100258765 | Others | ₹864 Cr | Satisfied |
To see the full charge records of Panacea Biotec Pharma Limited, buy the company report.
Total charge records: 2 View all charges
Deals & funding
Panacea Biotec Pharma Limited has 3 deals on record (2 debt financings, 1 acquisition), with disclosed funding of ₹808.43 Cr; the latest was in February 2022.
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Feb 2022 | Acquisition | ₹1,807.65 Cr | Buyer: Mankind Pharma Limited Seller: Panacea Biotec Pharma Limited |
| Oct 2020 | Debt financing | ₹96 Cr | Investors: IndiaRF, Piramal Structured Finance |
| Feb 2020 | Debt financing | ₹712.43 Cr | Investors: IndiaRF, Piramal Structured Finance |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Panacea Biotec Pharma Limited has 5 court cases on record: 1 filed by Panacea Biotec Pharma, 4 filed against it. 2 cases are pending and 3 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 2 | 2 |
| High courts | 2 | 2 | 0 |
Cases on record (5 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Chennai, Tamil Nadu | Execution petition | Filed against the company by an individual | Pending |
| District court, Chennai, Tamil Nadu | Petition | Filed against the company by an individual | Pending |
| High Court, HARYANA | Writ petition | Filed against the company by an individual | Disposed |
| High Court | Writ petition | Filed against the company by individuals | Disposed |
| District court, New Delhi, Delhi | Criminal case | Filed by the company against Manora Ghukul Enterprises | Disposed |
To see the full case history of Panacea Biotec Pharma Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Panacea Biotec Pharma Limited has 34 MSME Form 1 returns on record between 2020 and 2024, listing 1,642 overdue payments to 181 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 181)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Acechem Global | |||
| Eco Energy Industries | |||
| an individual supplier | |||
| Arizona Automation & Controls |
To see the full MSME payment records of Panacea Biotec Pharma Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Panacea Biotec Pharma Limited has a workforce of 940 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 940 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 |
To see the full employee and EPFO history of Panacea Biotec Pharma Limited, buy the company report.
GST
Panacea Biotec Pharma has 22 GST registrations: 21 active and 1 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAKCP4431B1ZQ | Delhi | Active | 16 Apr 2019 |
| 07AAKCP4431B2ZP | Delhi | Active | 04 Jul 2020 |
| 18AAKCP4431B1ZN | Assam | Active | 13 Aug 2019 |
| 24AAKCP4431B1ZU | Gujarat | Active | 14 Aug 2019 |
To see the full GST registrations and return filing status of Panacea Biotec Pharma Limited, buy the company report.
Recent activity
Panacea Biotec Pharma Limited has 17 board changes on record since 2019: 6 appointments and 11 cessations. The latest: Sanjay Trehan was appointed as Whole-Time Director on 13 Feb 2025.
13 earlier events are in the company report.
News
Frequently asked questions
Panacea Biotec Pharma is an active public limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 22 March 2019 (7+ years old) and is registered under CIN U24299DL2019PLC347566.
Panacea Biotec Pharma has 6 current directors:
- Rajesh Jain - Managing Director
- Ankesh Jain - Whole-Time Director
- Narotam Kumar Juneja - Whole-Time Director
- Sanjay Trehan - Whole-Time Director
- Rajesh Jain - Director
- Manjula Upadhyay - Director
The latest financial statements of Panacea Biotec Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Panacea Biotec Pharma is 07AAKCP4431B1ZQ, registered in Delhi. The company has 22 GST registrations in all, of which 21 are active and 1 is cancelled or inactive. Other active GSTINs include 07AAKCP4431B2ZP (Delhi), 18AAKCP4431B1ZN (Assam), 24AAKCP4431B1ZU (Gujarat).
The CIN (Corporate Identification Number) of Panacea Biotec Pharma is U24299DL2019PLC347566. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Panacea Biotec Pharma has 5 court cases on record: 1 filed by the company and 4 filed against it. 2 are pending. Most are in the district courts.
Panacea Biotec Pharma was incorporated on 22 March 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
Panacea Biotec Pharma has 3 deals on record (2 debt financings, 1 acquisition), with disclosed funding of ₹808.43 Cr; the latest was in February 2022.
The peers of Panacea Biotec Pharma by revenue are Amn Life Science Private Limited, Selmar Lab Private Limited, Psychotropics India Limited, all in the Healthcare industry (Formulations, Preventive Healthcare Supplements), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sanjay Trehan was appointed as Whole-Time Director on 13 Feb 2025. Sanjay Trehan ceased to be Additional Director on 13 Feb 2025. Rajesh Jain ceased to be Additional Director on 05 Dec 2024. Panacea Biotec Pharma has 17 board changes on record in total.
Panacea Biotec Pharma has 34 MSME Form 1 returns on record between 2020 and 2024, listing 1,642 overdue payments to 181 micro and small suppliers. The latest return was filed on 29 Apr 2024.
Panacea Biotec Pharma can be reached through the website panaceabiotec.com. Its registered office is in New Delhi, Delhi, India.

